Form D · Private Equity Fund
NV Pharma Capital Partners 01 LLC
Houston, TX · CIK 0001740597
Offering snapshot reported Apr 8, 2019 · SEC filing
- Reported sold
- $5.61M Offering amount: $5.61M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Apr 8, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 8, 2019 | Initial | $5,605,995 | No comparison | 3 | SEC filing |
| May 21, 2018 | Initial | $2,227,727 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-336675
Source: Form D, filed Apr 8, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Krenik | Executive |
| Kelley Rytlewski | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
2906 Fairhope
Houston, TX, 77025
Houston, TX, 77025